Clinical Trials for Cervical Carcinoma

Find clinical trials for cervical carcinoma. Discover research opportunities and treatment options in your area.

22 Active Trials Found

Showing 22 trials on this page

Page 1 of 2

PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

NCT ID: NCT05581121

The PARa-aOrtic LymphAdenectomy study is a clinical trial that aims to see if a specific surgical procedure called para-aortic lymphadenectomy, followed by personalized chemotherapy and radiation t...

Recruiting

Phase: PHASE3 Type: interventional Locations: Villejuif, , France, Paris, , France +28 more

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT ID: NCT02628067

This clinical trial is studying a medication called pembrolizumab (MK-3475) for people with advanced solid tumors that have not responded to standard treatments. The trial aims to see how well this...

Recruiting

Phase: PHASE2 Type: interventional Locations: North Ryde, , Australia, Midrand, , South Africa +29 more

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

NCT ID: NCT04567771

This clinical trial is looking at two types of radiation therapy—proton therapy and intensity-modulated radiation therapy (IMRT)—to see which one causes fewer side effects for women who have had su...

Recruiting

Phase: NA Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

NCT ID: NCT06967961

This clinical trial is studying a specific type of blood cells called double-positive circulating cells, which may help doctors better understand certain metastatic cancers—cancers that have spread...

Not yet recruiting

Phase: NA Type: interventional Locations: Toulouse, , France

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

NCT ID: NCT06611553

The Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial is looking at a new way for women to get tested for HPV, a virus that can lead to cervical cancer. Instead of ...

Recruiting

Phase: NA Type: interventional Locations: New Haven, Connecticut, United States, Cleveland, Ohio, United States +23 more

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

NCT ID: NCT06611540

The Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial is a study investigating whether women can collect their own vaginal samples for HPV testing. HPV, or human pa...

Recruiting

Phase: NA Type: interventional Locations: New Haven, Connecticut, United States, Cleveland, Ohio, United States +23 more

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

NCT ID: NCT04927650

This clinical trial is focused on preventing and finding cervical cancer early by allowing women to perform their own screening tests in Western Uganda. The cervix is the lower part of the uterus, ...

Recruiting

Type: observational Locations: Kampala, , Uganda

The Ohio State University (OSU) SCREEN Community Program

NCT ID: NCT06666192

The Ohio State University (OSU) SCREEN Community Program is a clinical trial aimed at increasing the number of women who get screened for breast, cervical, and colorectal cancers. These cancers can...

Recruiting

Phase: NA Type: interventional Locations: Columbus, Ohio, United States

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

NCT ID: NCT06498661

The Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial is studying a new approach to cervical cancer screening. The trial is looking at whether women can collect the...

Recruiting

Phase: NA Type: interventional Locations: New Haven, Connecticut, United States, Cleveland, Ohio, United States +25 more

Systemic and Tumor Immune Response During Pelvic (chemo)Radiation And/or Brachytherapy for Cervical Cancer

NCT ID: NCT06804135

This clinical trial is studying how different types of radiation therapy affect the immune response in women with cervical cancer. The researchers want to learn more about how radiation treatment c...

Not yet recruiting

Type: observational

Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers

NCT ID: NCT06800612

This clinical trial is studying the effectiveness and safety of different cancer drug therapies for treating breast and gynecologic cancers, which include early-stage and metastatic breast cancer, ...

Recruiting

Type: observational Locations: Bologna, , Italy

HPV Vaccine, Imiquimod, and Metformin Combination Trial

NCT ID: NCT06686043

This clinical trial is looking into a combination of treatments to see if they can help strengthen the immune system in women with certain types of cancers linked to the Human Papillomavirus (HPV),...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

NCT ID: NCT06492070

This clinical trial is studying two different ways to help prevent a common side effect of a chemotherapy drug called paclitaxel, which is often used to treat gynecological cancers like ovarian or ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +1 more

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT ID: NCT04459273

This clinical trial is exploring a new imaging technique called FAPi PET/CT to see how it can help identify and understand different types of cancer in patients. The study looks at how a special tr...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

NCT ID: NCT05795595

The clinical trial titled "A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors" is exploring a new treatment called CTX131 for adults with certa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nashville, Tennessee, United States, Duarte, California, United States +5 more

HPV16 E6 TCR T Cells for Cervical Carcinoma

NCT ID: NCT05357027

This clinical trial is studying a new treatment for cervical cancer that is linked to the human papillomavirus (HPV), specifically a protein called E6. The treatment involves taking a patient's own...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chongqing, Chongqing, China

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

NCT ID: NCT06241235

This clinical trial is studying a new treatment called ZG005, which is being tested together with standard chemotherapy drugs (Paclitaxel and Platinum-based drugs) and possibly another drug called ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Zhejiang, Hangzhou, China, Zhejiang, Hangzhou, China

Adaptive Radiotherapy in Patients With Gynecological Tumors

NCT ID: NCT06230549

This clinical trial is studying a type of treatment called adaptive radiotherapy for women with certain types of advanced gynecological cancers, such as cervical or endometrial cancer. The goal is ...

Recruiting

Phase: NA Type: interventional Locations: Essen, Germany / Nrw, Germany, Essen, , Germany

Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer

NCT ID: NCT05824468

This clinical trial is looking at a new treatment option for women with advanced cervical cancer who have not responded well to previous therapies, particularly immune checkpoint inhibitors. The st...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, , China

A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

NCT ID: NCT05366478

This clinical trial is studying a new treatment called LM103 Injection for patients with advanced solid tumors, specifically melanoma, non-small cell lung cancer, and cervical cancer. The goal of t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tianjin, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions